Design and characterization of novel cell-penetrating peptides from pituitary adenylate cyclase-activating polypeptide

Journal of Controlled Release

Volumn 163, Issue 2, 2012, Pages 256-265

  Doan, Ngoc Duc ^a,b   Létourneau, Myriam ^a,b   Vaudry, David ^b   Doucet, Nicolas ^a   Folch, Benjamin ^a   Vaudry, Hubert ^b   Fournier, Alain ^a,b   Chatenet, David ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b UNIVERSITÉ DE ROUEN   (France)

Author keywords

Cellular uptake; Drug delivery; Endogenous cell penetrating peptide; PACAP

Indexed keywords

ADENYLATE; CELL-PENETRATING PEPTIDE; CELLULAR UPTAKE; IN-VITRO; INTRACELLULAR COMPARTMENTS; INTRACELLULAR DELIVERY; ISOFORMS; LIPOFECTAMINE; NEUROPEPTIDES; NEW MEMBERS; PACAP; PHYSICOCHEMICAL PROPERTY; POLYNUCLEOTIDES; SMALL MOLECULES; STREPTAVIDIN; THERAPEUTIC APPLICATION; TOXIC EFFECT; TRANSFECTION AGENTS; UPTAKE MECHANISM;

BIOSYNTHESIS; CELLS; CHEMICAL PROPERTIES; CYTOLOGY; DRUG DELIVERY; LIPOSOMES; MOLECULES; NUCLEIC ACIDS; PEPTIDES;

MOLECULAR BIOLOGY;

CELL PENETRATING PEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 11 38; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 28; ISOPROTEIN; LIPOFECTAMINE; LIPOFECTAMINE 2000; POLYNUCLEOTIDE; STREPTAVIDIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CAVEOLA; CELL MEMBRANE; CIRCULAR DICHROISM; ENDOCYTOSIS; HUMAN; HUMAN CELL; NONHUMAN; PHYSICAL CHEMISTRY; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SYNTHESIS;

ANIMALS; CELL-PENETRATING PEPTIDES; CHO CELLS; CRICETINAE; CRICETULUS; DRUG DESIGN; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PLASMIDS; TRANSFECTION;

EID: 84866885416     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.08.021     Document Type: Article

References (36)

1. K.M. Stewart, K.L. Horton, and S.O. Kelley Cell-penetrating peptides as delivery vehicles for biology and medicine Org. Biomol. Chem. 6 13 2008 2242 2255 (Pubitemid 351863664)
2. F. Heitz, M.C. Morris, and G. Divita Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics Br. J. Pharmacol. 157 2 2009 195 206
3. R.M. Johnson, S.D. Harrison, and D. Maclean Therapeutic applications of cell-penetrating peptides Methods Mol. Biol. 683 2010 535 551
4. P. Jarver, I. Mager, and U. Langel In vivo biodistribution and efficacy of peptide mediated delivery Trends Pharmacol. Sci. 31 11 2010 528 535
5. S.A. Moschos, S.W. Jones, M.M. Perry, A.E. Williams, J.S. Erjefalt, J.J. Turner, P.J. Barnes, B.S. Sproat, M.J. Gait, and M.A. Lindsay Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity Bioconjug. Chem. 18 5 2007 1450 1459 (Pubitemid 47464052)
6. R. Rennert, I. Neundorf, and A.G. Beck-Sickinger Calcitonin-derived peptide carriers: mechanisms and application Adv. Drug Deliv. Rev. 60 4-5 2008 485 498
7. A. Miyata, A. Arimura, R.R. Dahl, N. Minamino, A. Uehara, L. Jiang, M.D. Culler, and D.H. Coy Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells Biochem. Biophys. Res. Commun. 164 1 1989 567 574 (Pubitemid 19269770)
8. D. Vaudry, B.J. Gonzalez, M. Basille, T.F. Pamantung, A. Fournier, and H. Vaudry PACAP acts as a neurotrophic factor during histogenesis of the rat cerebellar cortex Ann. N. Y. Acad. Sci. 921 2000 293 299 (Pubitemid 32094557)
9. D. Vaudry, A. Falluel-Morel, S. Bourgault, M. Basille, D. Burel, O. Wurtz, A. Fournier, B.K. Chow, H. Hashimoto, L. Galas, and H. Vaudry Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery Pharmacol. Rev. 61 3 2009 283 357
10. S. Bourgault, D. Chatenet, O. Wurtz, N.D. Doan, J. Leprince, H. Vaudry, A. Fournier, and D. Vaudry Strategies to convert PACAP from a hypophysiotropic neurohormone into a neuroprotective drug Curr. Pharm. Des. 17 10 2011 1002 1024
11. S. Bourgault, D. Vaudry, A. Dejda, N.D. Doan, H. Vaudry, and A. Fournier Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective Peptide Curr. Med. Chem. 16 33 2009 4462 4480
12. V. Wray, K. Nokihara, and S. Naruse Solution structure comparison of the VIP/PACAP family of peptides by NMR spectroscopy Ann. N. Y. Acad. Sci. 865 1998 37 44 (Pubitemid 29047809)
13. K.H. Sze, H. Zhou, Y. Yang, M. He, Y. Jiang, and A.O. Wong Pituitary adenylate cyclase-activating polypeptide (PACAP) as a growth hormone (GH)-releasing factor in grass carp: II. Solution structure of a brain-specific PACAP by nuclear magnetic resonance spectroscopy and functional studies on GH release and gene expression Endocrinology 148 10 2007 5042 5059 (Pubitemid 47481517)
14. Y. Umetsu, T. Tenno, N. Goda, M. Shirakawa, T. Ikegami, and H. Hiroaki Structural difference of vasoactive intestinal peptide in two distinct membrane-mimicking environments Biochim. Biophys. Acta 1814 5 2011 724 730
15. N.D. Doan, D. Chatenet, M. Letourneau, H. Vaudry, D. Vaudry, and A. Fournier Receptor-independent cellular uptake of pituitary adenylate cyclase-activating polypeptide Biochim. Biophys. Acta 1823 4 2012 940 949
16. G.G. Krivov, M.V. Shapovalov, and R.L. Dunbrack Jr. Improved prediction of protein side-chain conformations with SCWRL4 Proteins 77 4 2009 778 795
17. A.A. Canutescu, A.A. Shelenkov, and R.L. Dunbrack Jr. A graph-theory algorithm for rapid protein side-chain prediction Protein Sci. 12 9 2003 2001 2014 (Pubitemid 37022822)
18. T.J. Dolinsky, P. Czodrowski, H. Li, J.E. Nielsen, J.H. Jensen, G. Klebe, and N.A. Baker PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations Nucleic Acids Res. 35 Web Server issue 2007 W522 W525
19. T.J. Dolinsky, J.E. Nielsen, J.A. McCammon, and N.A. Baker PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations Nucleic Acids Res. 32 Web Server issue 2004 W665 W667
20. N.A. Baker, D. Sept, S. Joseph, M.J. Holst, and J.A. McCammon Electrostatics of nanosystems: application to microtubules and the ribosome Proc. Natl. Acad. Sci. 98 18 2001 10037 10041 (Pubitemid 32802969)
21. N.D. Doan, S. Bourgault, A. Dejda, M. Letourneau, M. Detheux, D. Vaudry, H. Vaudry, D. Chatenet, and A. Fournier Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects Biochem. Pharmacol. 81 4 2011 552 561
22. N.D. Doan, T.T.M. Nguyen, M. Letourneau, K. Turcotte, A. Fournier, and D. Chatenet Biochemical and pharmacological characterization of nuclear urotensin ii binding sites in rat heart Br. J. Pharmacol. 166 1 2012 243 257
23. J. Rinne, B. Albarran, J. Jylhava, T.O. Ihalainen, P. Kankaanpaa, V.P. Hytonen, P.S. Stayton, M.S. Kulomaa, and M. Vihinen-Ranta Internalization of novel non-viral vector TAT-streptavidin into human cells BMC Biotechnol. 7 2007 1
24. A. Vandermeers, S. Vandenborre, X. Hou, P. de Neef, P. Robberecht, M.C. Vandermeers-Piret, and J. Christophe Antagonistic properties are shifted back to agonistic properties by further N-terminal shortening of pituitary adenylate-cyclase-activating peptides in human neuroblastoma NB-OK-1 cell membranes Eur. J. Biochem. 208 3 1992 815 819
25. S. Bourgault, D. Vaudry, I. Segalas-Milazzo, L. Guilhaudis, A. Couvineau, M. Laburthe, H. Vaudry, and A. Fournier Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor J. Med. Chem. 52 10 2009 3308 3316
26. E. Vives Present and future of cell-penetrating peptide mediated delivery systems: is the Trojan horse too wild to go only to Troy? J. Control. Release 109 1-3 2005 77 85 (Pubitemid 41737254)
27. D.S. Mern, K. Hoppe-Seyler, F. Hoppe-Seyler, J. Hasskarl, and B. Burwinkel Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells Breast Cancer Res. Treat. 124 3 2010 623 633
28. F. Simeoni, M.C. Morris, F. Heitz, and G. Divita Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells Nucleic Acids Res. 31 11 2003 2717 2724 (Pubitemid 37442116)
29. S.E. Andaloussi, T. Lehto, I. Mager, K. Rosenthal-Aizman, I.I. Oprea, O.E. Simonson, H. Sork, K. Ezzat, D.M. Copolovici, K. Kurrikoff, J.R. Viola, E.M. Zaghloul, R. Sillard, H.J. Johansson, F. Said Hassane, P. Guterstam, J. Suhorutsenko, P.M. Moreno, N. Oskolkov, J. Halldin, U. Tedebark, A. Metspalu, B. Lebleu, J. Lehtio, C.I. Smith, and U. Langel Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo Nucleic Acids Res. 39 9 2011 3972 3987
30. R.M. Johnson, S.D. Harrison, and D. Maclean Therapeutic applications of cell-penetrating peptides Methods Mol. Biol. 683 2011 535 551
31. T. Borsello, P.G. Clarke, L. Hirt, A. Vercelli, M. Repici, D.F. Schorderet, J. Bogousslavsky, and C. Bonny A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia Nat. Med. 9 9 2003 1180 1186 (Pubitemid 37173703)
32. L. Hirt, J. Badaut, J. Thevenet, C. Granziera, L. Regli, F. Maurer, C. Bonny, and J. Bogousslavsky D-JNKI1, a cell-penetrating c-Jun-N-terminal kinase inhibitor, protects against cell death in severe cerebral ischemia Stroke 35 7 2004 1738 1743 (Pubitemid 38823657)
33. A. Ghosh, A. Roy, X. Liu, J.H. Kordower, E.J. Mufson, D.M. Hartley, S. Ghosh, R.L. Mosley, H.E. Gendelman, and K. Pahan Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease Proc. Natl. Acad. Sci. U. S. A. 104 47 2007 18754 18759 (Pubitemid 350210769)
34. P. Kumar, H. Wu, J.L. McBride, K.E. Jung, M.H. Kim, B.L. Davidson, S.K. Lee, P. Shankar, and N. Manjunath Transvascular delivery of small interfering RNA to the central nervous system Nature 448 7149 2007 39 43 (Pubitemid 47037001)
35. A. Rydstrom, S. Deshayes, K. Konate, L. Crombez, K. Padari, H. Boukhaddaoui, G. Aldrian, M. Pooga, and G. Divita Direct translocation as major cellular uptake for CADY self-assembling peptide-based nanoparticles PLoS One 6 10 2011 e25924
36. J.H. Kuo, M.S. Jan, Y.L. Lin, and C. Lin Interactions between octaarginine and U-937 human macrophages: global gene expression profiling, superoxide anion content, and cytokine production J. Control. Release 139 3 2009 197 204